Freshpet’s Q2 2026: Margin Momentum, Higher Outlook, and the “Fresh” Questions Ahead

Executive snapshot

Freshpet, Inc. reported Q2 2026 results that underscore a growing, more efficient manufacturing footprint and a multi-channel push that seems to be paying off. Net sales rose to $305.6 million, a 15.5% year-over-year climb, while gross margin expanded to 42.1% from 40.9% a year earlier. Adjusted gross margin followed suit at 48.6% (vs 46.9%). Net income came in at $19.5 million, with Adjusted EBITDA at $52.2 million. SG&A ran $107.0 million (35.0% of net sales), and Adjusted SG&A was $96.1 million (31.4% of net sales). A one-time equity-investment gain helped lift GAAP net income, a reminder that not all profit is baked into the cash register the same way every quarter. Management also indicated it is raising the 2026 net sales and Adjusted EBITDA outlook and reaffirming a long-term target for Adjusted Gross Margin above 49%.

Bottom line for investors peering at EPS and revenue forecasts: the company’s core business is growing, margins are improving, and the path to higher full-year guidance is supported by volume gains and leverage on plant costs. The press release emphasizes non-GAAP measures such as Adjusted EBITDA and Adjusted Gross Margin, with a standard footnote that these are reconciled in accompanying tables. The absence of a disclosed EPS figure in the excerpt means any discussion of EPS consensus versus actuals remains speculative for the moment.

Quarterly highlights in plain language

• Revenue trajectory: Net sales of $305.6 million, up 15.5% versus the prior year. The growth driver is described as volume gains (about 15.7%), with a modest negative price/mix impact (0.2%).
• Gross margin: 42.1% on net sales, up from 40.9% a year ago; Adjusted Gross Margin of 48.6% vs 46.9%. This is the kind of margin expansion investors like to see when volume is rising and input costs are behaving.
• Profitability: Net income of $19.5 million; Adjusted EBITDA of $52.2 million. The GAAP improvement is helped by a gain on equity investment, a one-off that’s common in corporate transactions but not a recurring driver of earnings power.
• Costs and spend: SG&A of $107.0 million (35.0% of net sales); Adjusted SG&A of $96.1 million (31.4% of net sales). Greater logistics costs and variable compensation partly offset by lower media spend as a share of net sales.
• Guidance: Management raised the 2026 net sales and Adjusted EBITDA outlook and reaffirmed a long-term Adjusted Gross Margin target above 49%.

The numbers themselves tell a straightforward story: top-line momentum is translating into margin improvement, while the company reins in the cost structure in some areas and shoulders higher spend in others to support scale. The equity investment gain is a reminder that the true core earnings track for a consumer company often hides behind non-operational line items in the short run.

Margin trajectory and the quality of the gain

The incremental gross margin expansion is the star of the quarter, driven by lower input costs and better leverage on plant-level overhead as production scales. Management notes the effect of new technology lines and cost discipline on the margin line, while cautioning that startup costs related to new equipment can temper margin progression in near-term quarters.

Adjusted metrics — including Adjusted Gross Margin and Adjusted EBITDA — paint a picture of ongoing operating discipline, even when GAAP results get a one-off lift or drag from non-operational items. The 1-for-1 translation of higher gross margins into higher profitability hinges on maintaining control over SG&A, logistics, and the variable components of compensation. In short: the recipe is trending toward more favorable mix, but the spice rack has some volatile notes to it.

Guidance and strategic context

The company raised its 2026 net sales outlook and its Adjusted EBITDA outlook, signaling confidence in continued volume growth and improved operating leverage. Importantly, Freshpet also raised its long-term target for Adjusted Gross Margin to greater than 49%. This combination matters because it implies a sustained push toward profitability even as the business scales, a dynamic many stand at the ready to document in long-run profitability charts.

The CEO’s closing remarks frame Freshpet’s strategy as “the fresh is the future of pet food” and emphasize scale, manufacturing efficiency, and an expanding omnichannel footprint as keys to growing market share and customer engagement. The statements accompany a narrative that the business can deliver higher margins as it expands production capacity and streamlines operations, while still investing in growth initiatives.

What this might portend for FRPT and sector peers

Today’s results suggest a few actionable angles for investors and rival pet-food manufacturers alike. First, the margin lift, anchored by improved input costs and plant-scale benefits, supports a narrative of sustainable profitability as volume grows. If the trajectory continues, the company could deliver higher earnings power even as it invests in capacity, which is attractive for equity holders who favor durable margin expansion alongside revenue growth.

Second, the raise to the revenue and profitability outlook reduces near-term execution risk, but the business remains exposed to input-cost volatility and logistics pressures. The company acknowledges these headwinds and explicitly flags higher logistics costs and variable compensation accruals as factors pressuring SG&A margins, even as media spend as a share of net sales trends downward. For peers, this is a reminder that cost discipline and supply-chain resilience are not optional add-ons; they are core components of a scalable margin story in consumer staples with a manufacturing tilt.

Finally, in the context of EPS and earnings surprises, the absence of a disclosed per-share figure in the summary means investors will watch the upcoming quarterly results for any divergence between GAAP EPS and the EPS consensus, if analysts publish one. The revenue forecast appears solid, and the improved gross margin target suggests that the market could reward continued progress on efficiency and top-line execution. In the sector, teams that can plausibly combine volume growth with margin discipline may find themselves with a leg up in the next earnings season.

Operational notes and why non-GAAP matters

The release reiterates that Adjusted Gross Margin, Adjusted Gross Profit, Adjusted SG&A, Adjusted EBITDA, and Free Cash Flow are non-GAAP financial measures, with reconciliations provided in the accompanying financial tables. This is standard fare, but it matters for anyone trying to translate the headline numbers into a true sense of ongoing profitability. The presence of a one-time equity investment gain in GAAP net income is a reminder that, when modeling earnings, the core operating leverage should be teased apart from non-core items.

Bottom line

Freshpet’s Q2 2026 results deliver a taste of upside: volume-driven net sales growth, margin expansion, and an elevated outlook that suggests management believes the earnings engine can keep running as the business scales. The non-GAAP narrative supports a story of improving core profitability, while the GAAP numbers remind us that not all profits are pure, especially when equity gains enter the fold.

For investors tracking FRPT, the key questions are whether inflationary pressures on inputs and logistics stabilize, whether the new manufacturing lines deliver the expected leverage, and how the company’s omnichannel strategy translates into sustained market share gains. The answer will likely hinge on the sustainability of the volume growth and the degree to which the company can protect and expand its gross margins while funding growth initiatives. If you’re penciling an earnings surprise on your model, the current trajectory makes a case for modest upside—but with the caveat that non-operational items can blur the true operating narrative in the near term.